This article is more than 5 years old. Information may no longer be current.
VIDEO: Higher, escalating cancer drug prices affect global health care system
Click Here to Manage Email Alerts
CHICAGO — Brian Bolwell, MD, chairman of the Taussig Cancer Institute at Cleveland Clinic, discusses results of a study presented at the ASCO Annual Meeting that evaluated the affordability of higher, escalating drug prices for cancer treatments in the United Sates and other countries.
Both generic and patented drug prices appeared highest in the United States, where drug price escalation was reported to be as high as 44% over several years.
In addition to its effect on the health care system, Bolwell noted these prices have negative implications on patients as well.
“Figuring out how to work with pharma to try to moderate this sort of drug pricing is utterly imperative both for the health care economy, as well as for our citizens,” he said.